A modest US$0.30 lift in the price target for Arcos Dorados Holdings has drawn fresh attention to how analysts are fine tuning their views on the stock. Bullish voices see the higher target as a ...
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results